Ozempic Price Drop in Medicare Talks Sends Novo Nordisk Stock Tumbling
The Centers for Medicare & Medicaid Services (CMS) has announced the selection of 15 additional drugs for its second round of price negotiations,a move that could substantially impact the cost of medications for millions of Americans. Among the drugs chosen are the widely popular weight loss medications Ozempic and Wegovy, which have seen a … Read more
